Systasy Bioscience GmbH products
Systasy - Proprietary splitSENSOR Technology
The proprietary splitSENSOR technology is a highly sensitive,flexible and easy-to-use reporter assay system to monitor various cellular events in living cells, including the activity of drug targets. Various cellular events, such as regulated protein-protein interactions, can be robustly and quantitatively measured both at the membrane and in the cytosol of the cell. This feature makes it, for example, an invaluable tool to assess the activity of receptors as measured by the regulated binding to their cognate cytosolic adapters. Therefore, this technology can be applied in particular to assess compound actions on drug targets, such as G protein-coupled receptors and receptor tyrosine kinases.
Systasy - Pathway-Centric Disease Screening Profiler
DiseasePROFILER employs Pathway-centric lead discovery in pooled cohorts using multi-level barcoding strategies. The DiseasePROFILER uses a subset of top-performing sensors identified in the PathwayPROFILER assay and enables simple, robust, and cost-effective screening of compound effects in human disease models.
Systasy - High Content Pathway Identification Profiler
The Pathway PROFILER assay addresses 100 individual signaling events that can be simultaneously analyzed using the EXTassay technology. For a clear and strong analysis, individual signaling events are grouped into seven major signaling clusters covering regulation of cellular stress, cell fate, metabolism, immune response, stem cell pluripotency, synaptic activity & calcium signaling, and immediate early gene (IEG) response.
Systasy - Artificial Intelligence (AI) Technology
Cellular Signatures/Disease Patterns and High Dimensional clinical dataset analysis by Artificial Intelligence (AI)/
Systasy - Human Cellular & Humanized Mouse Models
Adult Human iNeurons: A next generation Drug Screening Platform for Mental Disorders.